FCN
FOSFOMYCIN
Created: | 1999-07-08 |
Last modified: | 2021-03-13 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 15 |
Chiral Atom Count | 2 |
Bond Count | 15 |
Aromatic Bond Count | 0 |
Chemical Component Summary | |
---|---|
Name | FOSFOMYCIN |
Synonyms | 1,2-EPOXYPROPYLPHOSPHONIC ACID |
Systematic Name (OpenEye OEToolkits) | [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid |
Formula | C3 H7 O4 P |
Molecular Weight | 138.059 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=P(O)(O)C1OC1C |
SMILES | CACTVS | 3.341 | C[CH]1O[CH]1[P](O)(O)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | CC1C(O1)P(=O)(O)O |
Canonical SMILES | CACTVS | 3.341 | C[C@@H]1O[C@@H]1[P](O)(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C[C@H]1[C@H](O1)P(=O)(O)O |
InChI | InChI | 1.03 | InChI=1S/C3H7O4P/c1-2-3(7-2)8(4,5)6/h2-3H,1H3,(H2,4,5,6)/t2-,3+/m0/s1 |
InChIKey | InChI | 1.03 | YMDXZJFXQJVXBF-STHAYSLISA-N |
Drug Info: DrugBank
DrugBank ID | DB00828 |
---|---|
Name | Fosfomycin |
Groups | approved |
Description | Fosfomycin was discovered in 1969 by scientists at the Spanish Penicillin and Antibiotics Company and is produced by _Streptomyces fradiae_.[A229338,A230348] It may also be produced synthetically and is commercially available as the disodium salt for intravenous administration and as the calcium or trometamol salt for oral administration.[A230348] In terms of chemical structure, fosfomycin is a phosphoenolpyruvate analog and contains a phosphonic group and an epoxide ring.[A230348] Due to its ease of administration as a single 3-gram oral dose and desirable safety profile, fosfomycin has largely become a first-line therapeutic option for the treatment of uncomplicated urinary tract infections (UTIs) in females.[A230378] Despite being FDA approved only for urinary tract infections, fosfomycin actually has a broad spectrum of activity and is active against both gram-positive and gram-negative bacteria.[A230348] As such there is great interest in exploring the usefulness of fosfomycin for indications beyond the treatment of UTIs.[A230353,A230358] |
Synonyms |
|
Brand Names |
|
Indication | Fosfomycin is indicated for the treatment of uncomplicated cases of cystitis caused by susceptible strains of _Escherichia coli_ and _Enterococcus faecalis_.[L31818] Fosfomycin is not officially indicated for the treatment of pyelonephritis or perinephric abscess, although there have been reported cases of off-label usage in these situations.[L31818] |
Categories |
|
ATC-Code |
|
CAS number | 23155-02-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
UDP-N-acetylglucosamine 1-carboxyvinyltransferase | MDKFRVQGPTKLQGEVTISGAKNAALPILFAALLAEEPVEIQNVPKLKDV... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 446987 |
ChEMBL | CHEMBL1757 |
ChEBI | CHEBI:28915 |